Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.

Venkatesan S, Myles PR, Bolton KJ, Muthuri SG, Al Khuwaitir T, Anovadiya AP, Azziz-Baumgartner E, Bajjou T, Bassetti M, Beovic B, Bertisch B, Bonmarin I, Booy R, Borja-Aburto VH, Burgmann H, Cao B, Carratala J, Chinbayar T, Cilloniz C, Denholm JT, Dominguez SR, Duarte PAD, Dubnov-Raz G, Fanella S, Gao Z, Gérardin P, Giannella M, Gubbels S, Herberg J, Higuera Iglesias AL, Hoeger PH, Hu XY, Islam QT, Jiménez MF, Keijzers G, Khalili H, Kusznierz G, Kuzman I, Langenegger E, Lankarani KB, Leo YS, Libster RP, Linko R, Madanat F, Maltezos E, Mamun A, Manabe T, Metan G, Mickiene A, Mikić D, Mohn KGI, Oliva ME, Ozkan M, Parekh D, Paul M, Rath BA, Refaey S, Rodríguez AH, Sertogullarindan B, Skręt-Magierło J, Somer A, Talarek E, Tang JW, To K, Tran D, Uyeki TM, Vaudry W, Vidmar T, Zarogoulidis P; PRIDE Consortium Investigators , Nguyen-Van-Tam JS.

J Infect Dis. 2019 Jul 17. pii: jiz152. doi: 10.1093/infdis/jiz152. [Epub ahead of print]

PMID:
31314899
2.

Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis.

Li Y, Reeves RM, Wang X, Bassat Q, Brooks WA, Cohen C, Moore DP, Nunes M, Rath B, Campbell H, Nair H; RSV Global Epidemiology Network; RESCEU investigators.

Lancet Glob Health. 2019 Aug;7(8):e1031-e1045. doi: 10.1016/S2214-109X(19)30264-5.

3.

Incidence, Severity and Impact of Influenza: a joint meeting organised by the ISIRV Epidemiology Group and ECDC, Stockholm, 2019.

Rath B, Penttinen P.

Euro Surveill. 2020 Jun;24(23). doi: 10.2807/1560-7917.ES.2019.24.23.1900348. No abstract available.

4.

Partnering for enhanced digital surveillance of influenza-like disease and the effect of antivirals and vaccines (PEDSIDEA).

Rath B, Maltezou HC, Papaevangelou V, Papagrigoriou-Theodoridou MA, Alchikh M, Myles P, Schweiger B; PEDSIDEA Network.

Influenza Other Respir Viruses. 2019 Jul;13(4):309-318. doi: 10.1111/irv.12645. Epub 2019 Jun 6.

5.

Interaction of Adipose-Derived Stromal Cells with Breast Cancer Lines."

Teufelsbauer M, Rath B, Moser D, Haslik W, Huk I, Hamilton G.

Plast Reconstr Surg. 2019 May 7. doi: 10.1097/PRS.0000000000005839. [Epub ahead of print]

PMID:
31107788
6.

Immunotherapy for small cell lung cancer: mechanisms of resistance.

Hamilton G, Rath B.

Expert Opin Biol Ther. 2019 May;19(5):423-432. doi: 10.1080/14712598.2019.1592155. Epub 2019 Mar 18.

PMID:
30855195
7.

Molecular Evolution of Human Adenovirus (HAdV) Species C.

Dhingra A, Hage E, Ganzenmueller T, Böttcher S, Hofmann J, Hamprecht K, Obermeier P, Rath B, Hausmann F, Dobner T, Heim A.

Sci Rep. 2019 Jan 31;9(1):1039. doi: 10.1038/s41598-018-37249-4.

8.

Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines.

Rath B, Klameth L, Plangger A, Hochmair M, Ulsperger E, Huk I, Zeillinger R, Hamilton G.

Cancers (Basel). 2019 Jan 19;11(1). pii: E114. doi: 10.3390/cancers11010114.

9.

Applicability of tumor spheroids for in vitro chemosensitivity assays.

Hamilton G, Rath B.

Expert Opin Drug Metab Toxicol. 2019 Jan;15(1):15-23. doi: 10.1080/17425255.2019.1554055. Epub 2018 Dec 2. Review.

PMID:
30484335
10.

Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines.

Rath B, Hochmair M, Plangger A, Hamilton G.

Mar Drugs. 2018 Oct 14;16(10). pii: E383. doi: 10.3390/md16100383.

11.

Can we distinguish respiratory viral infections based on clinical features? A prospective pediatric cohort compared to systematic literature review.

Ma X, Conrad T, Alchikh M, Reiche J, Schweiger B, Rath B.

Rev Med Virol. 2018 Sep;28(5):e1997. doi: 10.1002/rmv.1997. Epub 2018 Jul 24. Review.

PMID:
30043515
12.

The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo.

Wahba A, Rath BH, O'Neill JW, Camphausen K, Tofilon PJ.

Mol Cancer Ther. 2018 Aug;17(8):1717-1726. doi: 10.1158/1535-7163.MCT-17-1303. Epub 2018 Jun 4.

PMID:
29866745
13.

The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and as Orthotopic Xenografts.

Timme CR, Rath BH, O'Neill JW, Camphausen K, Tofilon PJ.

Mol Cancer Ther. 2018 Jun;17(6):1207-1216. doi: 10.1158/1535-7163.MCT-17-1267. Epub 2018 Mar 16.

14.

Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity.

Rath BH, Waung I, Camphausen K, Tofilon PJ.

Mol Cancer Ther. 2018 May;17(5):1070-1078. doi: 10.1158/1535-7163.MCT-17-1053. Epub 2018 Feb 26.

15.

Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1.

Hamilton G, Rath B.

Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):17-24. doi: 10.1080/17425255.2018.1416095. Epub 2017 Dec 18. Review.

PMID:
29226731
16.

Vienna Vaccine Safety Initiative.

Rath B.

Hum Vaccin Immunother. 2018 May 4;14(5):1038-1041. doi: 10.1080/21645515.2017.1412666. Epub 2018 Jan 23. No abstract available.

17.

Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series.

Scheltema NM, Gentile A, Lucion F, Nokes DJ, Munywoki PK, Madhi SA, Groome MJ, Cohen C, Moyes J, Thorburn K, Thamthitiwat S, Oshitani H, Lupisan SP, Gordon A, Sánchez JF, O'Brien KL; PERCH Study Group, Gessner BD, Sutanto A, Mejias A, Ramilo O, Khuri-Bulos N, Halasa N, de-Paris F, Pires MR, Spaeder MC, Paes BA, Simões EAF, Leung TF, da Costa Oliveira MT, de Freitas Lázaro Emediato CC, Bassat Q, Butt W, Chi H, Aamir UB, Ali A, Lucero MG, Fasce RA, Lopez O, Rath BA, Polack FP, Papenburg J, Roglić S, Ito H, Goka EA, Grobbee DE, Nair H, Bont LJ.

Lancet Glob Health. 2017 Oct;5(10):e984-e991. doi: 10.1016/S2214-109X(17)30344-3. Erratum in: Lancet Glob Health. 2017 Dec;5(12 ):e1190.

18.

Circulating tumor cell interactions with macrophages: implications for biology and treatment.

Hamilton G, Rath B.

Transl Lung Cancer Res. 2017 Aug;6(4):418-430. doi: 10.21037/tlcr.2017.07.04. Review.

19.

In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell Lines.

Klameth L, Rath B, Hamilton G.

J Cancer. 2017 Jul 1;8(10):1733-1743. doi: 10.7150/jca.17816. eCollection 2017.

20.

Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example.

Eke I, Makinde AY, Aryankalayil MJ, Sandfort V, Palayoor ST, Rath BH, Liotta L, Pierobon M, Petricoin EF, Brown MF, Stommel JM, Ahmed MM, Coleman CN.

Mol Cancer Ther. 2018 Feb;17(2):355-367. doi: 10.1158/1535-7163.MCT-17-0262. Epub 2017 Aug 11.

21.

Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance.

Klameth L, Rath B, Hochmaier M, Moser D, Redl M, Mungenast F, Gelles K, Ulsperger E, Zeillinger R, Hamilton G.

Sci Rep. 2017 Jul 13;7(1):5337. doi: 10.1038/s41598-017-05562-z.

22.

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.

Shi T, McAllister DA, O'Brien KL, Simoes EAF, Madhi SA, Gessner BD, Polack FP, Balsells E, Acacio S, Aguayo C, Alassani I, Ali A, Antonio M, Awasthi S, Awori JO, Azziz-Baumgartner E, Baggett HC, Baillie VL, Balmaseda A, Barahona A, Basnet S, Bassat Q, Basualdo W, Bigogo G, Bont L, Breiman RF, Brooks WA, Broor S, Bruce N, Bruden D, Buchy P, Campbell S, Carosone-Link P, Chadha M, Chipeta J, Chou M, Clara W, Cohen C, de Cuellar E, Dang DA, Dash-Yandag B, Deloria-Knoll M, Dherani M, Eap T, Ebruke BE, Echavarria M, de Freitas Lázaro Emediato CC, Fasce RA, Feikin DR, Feng L, Gentile A, Gordon A, Goswami D, Goyet S, Groome M, Halasa N, Hirve S, Homaira N, Howie SRC, Jara J, Jroundi I, Kartasasmita CB, Khuri-Bulos N, Kotloff KL, Krishnan A, Libster R, Lopez O, Lucero MG, Lucion F, Lupisan SP, Marcone DN, McCracken JP, Mejia M, Moisi JC, Montgomery JM, Moore DP, Moraleda C, Moyes J, Munywoki P, Mutyara K, Nicol MP, Nokes DJ, Nymadawa P, da Costa Oliveira MT, Oshitani H, Pandey N, Paranhos-Baccalà G, Phillips LN, Picot VS, Rahman M, Rakoto-Andrianarivelo M, Rasmussen ZA, Rath BA, Robinson A, Romero C, Russomando G, Salimi V, Sawatwong P, Scheltema N, Schweiger B, Scott JAG, Seidenberg P, Shen K, Singleton R, Sotomayor V, Strand TA, Sutanto A, Sylla M, Tapia MD, Thamthitiwat S, Thomas ED, Tokarz R, Turner C, Venter M, Waicharoen S, Wang J, Watthanaworawit W, Yoshida LM, Yu H, Zar HJ, Campbell H, Nair H; RSV Global Epidemiology Network.

Lancet. 2017 Sep 2;390(10098):946-958. doi: 10.1016/S0140-6736(17)30938-8. Epub 2017 Jul 7. Review.

23.

Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.

Hamilton G, Rath B.

Adv Exp Med Biol. 2017;994:229-245. doi: 10.1007/978-3-319-55947-6_12. Review.

PMID:
28560677
24.

Influenza and other respiratory viruses: standardizing disease severity in surveillance and clinical trials.

Rath B, Conrad T, Myles P, Alchikh M, Ma X, Hoppe C, Tief F, Chen X, Obermeier P, Kisler B, Schweiger B.

Expert Rev Anti Infect Ther. 2017 Jun;15(6):545-568. doi: 10.1080/14787210.2017.1295847. Epub 2017 May 12. Review.

PMID:
28277820
25.

Avelumab: combining immune checkpoint inhibition and antibody-dependent cytotoxicity.

Hamilton G, Rath B.

Expert Opin Biol Ther. 2017 Apr;17(4):515-523. doi: 10.1080/14712598.2017.1294156. Epub 2017 Feb 22. Review.

PMID:
28274143
26.

Prospective surveillance of antiviral resistance in hospitalized infants less than 12 months of age with A(H3N2) influenza infection and treated with oseltamivir.

Rath B, Chen X, Spies V, Muehlhans S, Obermeier P, Tief F, Seeber L, Karsch K, Milde J, Skopnik H, Schweiger B, Duwe SC.

Antivir Ther. 2017;22(6):515-522. doi: 10.3851/IMP3141. Epub 2017 Feb 16.

PMID:
28205506
27.

Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis.

Venkatesan S, Myles PR, Leonardi-Bee J, Muthuri SG, Al Masri M, Andrews N, Bantar C, Dubnov-Raz G, Gérardin P, Koay ESC, Loh TP, Memish Z, Miller E, Oliva ME, Rath BA, Schweiger B, Tang JW, Tran D, Vidmar T, Waight PA, Nguyen-Van-Tam JS.

Clin Infect Dis. 2017 May 15;64(10):1328-1334. doi: 10.1093/cid/cix127.

28.

Educating parents about the vaccination status of their children: A user-centered mobile application.

Seeber L, Conrad T, Hoppe C, Obermeier P, Chen X, Karsch K, Muehlhans S, Tief F, Boettcher S, Diedrich S, Schweiger B, Rath B.

Prev Med Rep. 2017 Jan 14;5:241-250. doi: 10.1016/j.pmedr.2017.01.002. eCollection 2017 Mar.

29.

Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept Study.

Hoppe C, Obermeier P, Muehlhans S, Alchikh M, Seeber L, Tief F, Karsch K, Chen X, Boettcher S, Diedrich S, Conrad T, Kisler B, Rath B.

Drug Saf. 2016 Oct;39(10):977-88. doi: 10.1007/s40264-016-0437-6.

PMID:
27350063
30.

Detection of circulating tumor cells in non-small cell lung cancer.

Hamilton G, Rath B.

J Thorac Dis. 2016 Jun;8(6):1024-8. doi: 10.21037/jtd.2016.03.86. No abstract available.

31.

Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data.

Rath B, Gidudu JF, Anyoti H, Bollweg B, Caubel P, Chen YH, Cornblath D, Fernandopulle R, Fries L, Galama J, Gibbs N, Grilli G, Grogan P, Hartmann K, Heininger U, Hudson MJ, Izurieta HS, Jevaji I, Johnson WM, Jones J, Keller-Stanislawski B, Klein J, Kohl K, Kokotis P, Li Y, Linder T, Oleske J, Richard G, Shafshak T, Vajdy M, Wong V, Sejvar J; Brighton Collaboration Bell's Palsy Working Group.

Vaccine. 2017 Apr 4;35(15):1972-1983. doi: 10.1016/j.vaccine.2016.05.023. Epub 2016 May 24. No abstract available.

PMID:
27235092
32.

Small cell lung cancer: Recruitment of macrophages by circulating tumor cells.

Hamilton G, Rath B, Klameth L, Hochmair MJ.

Oncoimmunology. 2015 Oct 29;5(3):e1093277. eCollection 2016 Mar.

33.

Polysome Profiling Links Translational Control to the Radioresponse of Glioblastoma Stem-like Cells.

Wahba A, Rath BH, Bisht K, Camphausen K, Tofilon PJ.

Cancer Res. 2016 May 15;76(10):3078-87. doi: 10.1158/0008-5472.CAN-15-3050. Epub 2016 Mar 22.

34.

Pharmacokinetics of Oral and Intravenous Oseltamivir Treatment of Severe Influenza B Virus Infection Requiring Organ Replacement Therapy.

Karsch K, Chen X, Miera O, Peters B, Obermeier P, Francis RC, Amann V, Duwe S, Fraaij P, Heider A, de Zwart M, Berger F, Osterhaus A, Schweiger B, Rath B.

Eur J Drug Metab Pharmacokinet. 2017 Feb;42(1):155-164. doi: 10.1007/s13318-016-0330-9.

PMID:
26994602
35.

Enabling Precision Medicine With Digital Case Classification at the Point-of-Care.

Obermeier P, Muehlhans S, Hoppe C, Karsch K, Tief F, Seeber L, Chen X, Conrad T, Boettcher S, Diedrich S, Rath B.

EBioMedicine. 2016 Jan 12;4:191-6. doi: 10.1016/j.ebiom.2016.01.008. eCollection 2016 Feb.

36.

Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cells.

Hamilton G, Rath B, Holzer S, Hochmair M.

Transl Lung Cancer Res. 2016 Feb;5(1):71-7. doi: 10.3978/j.issn.2218-6751.2015.12.12.

37.

Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.

Hamilton G, Hochmair M, Rath B, Klameth L, Zeillinger R.

Cell Adh Migr. 2016 Jul 3;10(4):360-7. doi: 10.1080/19336918.2016.1155019. Epub 2016 Feb 26.

38.

An inception cohort study assessing the role of pneumococcal and other bacterial pathogens in children with influenza and ILI and a clinical decision model for stringent antibiotic use.

Tief F, Hoppe C, Seeber L, Obermeier P, Chen X, Karsch K, Mühlhans S, Adamou E, Conrad T, Beresniak A, Schweiger B, Adam T, Rath B.

Antivir Ther. 2016;21(5):413-24. doi: 10.3851/IMP3034. Epub 2016 Feb 11.

PMID:
26867096
39.

Acute Disseminated Encephalomyelitis After Human Parechovirus Infection.

Obermeier PE, Karsch K, Hoppe C, Seeber L, Schneider J, Mühlhans S, Chen X, Tief F, Kaindl AM, Weschke B, Böttcher S, Diedrich S, Rath B.

Pediatr Infect Dis J. 2016 Jan;35(1):35-8. doi: 10.1097/INF.0000000000000928.

PMID:
26741581
40.

Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis.

Shi T, Balsells E, Wastnedge E, Singleton R, Rasmussen ZA, Zar HJ, Rath BA, Madhi SA, Campbell S, Vaccari LC, Bulkow LR, Thomas ED, Barnett W, Hoppe C, Campbell H, Nair H.

J Glob Health. 2015 Dec;5(2):020416. doi: 10.7189/jogh.05.020416. Review.

41.

Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.

Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Lim WS, Al Mamun A, Anovadiya AP, Araújo WN, Azziz-Baumgartner E, Báez C, Bantar C, Barhoush MM, Bassetti M, Beovic B, Bingisser R, Bonmarin I, Borja-Aburto VH, Cao B, Carratala J, Cuezzo MR, Denholm JT, Dominguez SR, Duarte PA, Dubnov-Raz G, Echavarria M, Fanella S, Fraser J, Gao Z, Gérardin P, Giannella M, Gubbels S, Herberg J, Higuera Iglesias AL, Hoeger PH, Hoffmann M, Hu X, Islam QT, Jiménez MF, Kandeel A, Keijzers G, Khalili H, Khandaker G, Knight M, Kusznierz G, Kuzman I, Kwan AM, Lahlou Amine I, Langenegger E, Lankarani KB, Leo YS, Linko R, Liu P, Madanat F, Manabe T, Mayo-Montero E, McGeer A, Memish ZA, Metan G, Mikić D, Mohn KG, Moradi A, Nymadawa P, Ozbay B, Ozkan M, Parekh D, Paul M, Poeppl W, Polack FP, Rath BA, Rodríguez AH, Siqueira MM, Skręt-Magierło J, Talarek E, Tang JW, Torres A, Törün SH, Tran D, Uyeki TM, van Zwol A, Vaudry W, Velyvyte D, Vidmar T, Zarogoulidis P; PRIDE Consortium Investigators, Nguyen-Van-Tam JS.

Influenza Other Respir Viruses. 2016 May;10(3):192-204. doi: 10.1111/irv.12363. Epub 2016 Feb 1.

42.

Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.

Rath BH, Wahba A, Camphausen K, Tofilon PJ.

Cancer Med. 2015 Nov;4(11):1705-16. doi: 10.1002/cam4.510. Epub 2015 Oct 30.

43.

How to target small cell lung cancer.

Hamilton G, Rath B, Ulsperger E.

Oncoscience. 2015 Aug 21;2(8):684-92. eCollection 2015.

44.

Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer.

Hamilton G, Rath B, Klameth L, Hochmair M.

Oncoscience. 2015 Jul 31;2(7):629-34. eCollection 2015.

45.

Smoking, inflammation and small cell lung cancer: recent developments.

Hamilton G, Rath B.

Wien Med Wochenschr. 2015 Oct;165(19-20):379-86. doi: 10.1007/s10354-015-0381-6. Epub 2015 Aug 20. Review.

PMID:
26289596
46.

Chitinase-3-like-1/YKL-40 as marker of circulating tumor cells.

Hamilton G, Rath B, Burghuber O.

Transl Lung Cancer Res. 2015 Jun;4(3):287-91. doi: 10.3978/j.issn.2218-6751.2015.04.04. Review.

47.

Global lessons from Nigeria's ebolavirus control strategy.

Elemuwa C, Kutalek R, Ali M, Mworozi E, Kochhar S, Rath B; Vienna Vaccine Safety Initiative.

Expert Rev Vaccines. 2015;14(11):1397-400. doi: 10.1586/14760584.2015.1064313. Epub 2015 Jul 18.

PMID:
26190046
48.

Human Parechovirus Infections Associated with Seizures and Rash in Infants and Toddlers.

Karsch K, Obermeier P, Seeber L, Chen X, Tief F, Mühlhans S, Hoppe C, Conrad T, Böttcher S, Diedrich S, Rath B.

Pediatr Infect Dis J. 2015 Oct;34(10):1049-55. doi: 10.1097/INF.0000000000000802.

PMID:
26181895
49.

Safety, virology and pharmacokinetics of oseltamivir in infants with laboratory-confirmed influenza: a Phase I/II, prospective, open-label, multicentre clinical trial.

Rath BA, Brzostek J, Guillén S, Niranjan V, Chappey C, Rayner CR, Clinch B.

Antivir Ther. 2015;20(8):815-25. doi: 10.3851/IMP2967. Epub 2015 May 27.

PMID:
26015411
50.

Communicating vaccine safety to the media and general public.

Oubari H, Tuttle R, Rath B, Bravo L.

Curr Drug Saf. 2015;10(1):80-6.

PMID:
25859680

Supplemental Content

Loading ...
Support Center